- Trials with a EudraCT protocol (1,712)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (94)
1,712 result(s) found for: Hypertension.
Displaying page 1 of 86.
EudraCT Number: 2007-000310-36 | Sponsor Protocol Number: 2542 | Start Date*: 2007-04-05 | |||||||||||
Sponsor Name:Radboud University Medical Center Njmegen | |||||||||||||
Full Title: Does statin therapy reduce sympathoexcitation in hypertension | |||||||||||||
Medical condition: hypertension and sympathoexcitation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017831-16 | Sponsor Protocol Number: 26169 | Start Date*: 2010-07-15 | |||||||||||||||||||||||||||||||
Sponsor Name:Institute of pharmacology, Aarhus university | |||||||||||||||||||||||||||||||||
Full Title: Effects of 6 months intensive vasodilating treatment on vascular resistance and coronary flow reserve in hypertensive patients | |||||||||||||||||||||||||||||||||
Medical condition: Essential Hypertension and changes in the vasculature related to high blood pressure. | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014534-15 | Sponsor Protocol Number: NACIPP | Start Date*: 2009-10-01 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | |||||||||||||
Full Title: EFFECT OF ACUTE ADMINISTRATION OF N-ACETYLCYSTEINE ON BLOOD PRESSURE OF PULMONARY ARTERIAL IN PRIMARY PULMONARY HYPERTENSION. | |||||||||||||
Medical condition: PRIMARY PULMONARY HYPERTENSION | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000077-22 | Sponsor Protocol Number: CL2-90652-001 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
Full Title: Acceptability, safety, pharmacokinetics and effects on blood pressure of a daily dose of 0.025 to 0.135 milligram per kilogram of S 90652, a paediatric formulation of perindopril, in 2-16 years old... | |||||||||||||
Medical condition: Arterial hypertension | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-003144-23 | Sponsor Protocol Number: PANDA | Start Date*: 2014-02-03 | |||||||||||||||||||||
Sponsor Name:King's College London [...] | |||||||||||||||||||||||
Full Title: Pregnancy And chronic hypertension: NifeDipine or labetalol as Antihypertensive treatment | |||||||||||||||||||||||
Medical condition: Chronic hypertension in pregnancy | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-003955-37 | Sponsor Protocol Number: CL3-05590-022 | Start Date*: 2005-03-29 | |||||||||||
Sponsor Name:INSTITUT DE RECHERCHES INTERNATIONALES SERVIER | |||||||||||||
Full Title: Efficacy of perindopril/indapamide combination on coronary Pet Scan parameters. A 6 month, open non controlled stydy in hypertensive patients | |||||||||||||
Medical condition: Essential arterial hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-003847-37 | Sponsor Protocol Number: REM 04 15 | Start Date*: 2004-12-21 | |||||||||||
Sponsor Name:BIOPROJET | |||||||||||||
Full Title: An Open label uncontrolled study of the safety and efficacy of chronic intravenous Remodulin in patients with pulmonary Arterial Hypertension | |||||||||||||
Medical condition: Pulmonary Arterial Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004411-22 | Sponsor Protocol Number: CSPP100A2365E2 | Start Date*: 2012-03-14 | ||||||||||||||||
Sponsor Name:Novartis Pharma Services AG | ||||||||||||||||||
Full Title: A multicenter, 52 to 104 week extension study to evaluate the long term growth and development of pediatric hypertensive patients 6 – 17 years of age treated previously with aliskiren | ||||||||||||||||||
Medical condition: Hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: Outside EU/EEA SK (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-000347-14 | Sponsor Protocol Number: PROCLAIM | Start Date*: 2016-06-16 | ||||||||||||||||
Sponsor Name:IDIBAPS | ||||||||||||||||||
Full Title: Cell proliferation in pulmonary hypertension: mollecular imaging detection by FDG PET. Comparative study between patients and healthy subjects | ||||||||||||||||||
Medical condition: Pulmonary artery hypertension and thromboembolic chronic pulmonary hypertension | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000194-21 | Sponsor Protocol Number: 150/04 | Start Date*: 2004-12-31 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA | |||||||||||||
Full Title: Effetti della L-argina nella profilassi della ipertensione cronica dal secondo trimestre di gravidanza | |||||||||||||
Medical condition: Profilassi della ipertensione cronica dal secondo trimestre di gravidanza | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001893-24 | Sponsor Protocol Number: Bay63-2521/14986 | Start Date*: 2011-10-13 | |||||||||||||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||||||||||||
Full Title: Relative bioavailability and food effect study of two oral liquid formulations in comparison to a 1mg tablet of riociguat to characterize its pharmacokinetic properties in healthy male and female a... | |||||||||||||||||||||||
Medical condition: Children with PH due to • Pulmonary arterial hypertension (PAH) • persistent pulmonary hypertension of the newborn (PPHN) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-004938-16 | Sponsor Protocol Number: 00-MEP-04 | Start Date*: 2008-02-19 | |||||||||||
Sponsor Name:Astellas Pharma Europe B.V. | |||||||||||||
Full Title: A RANDOMISED, DOUBLE-BLIND STUDY TO COMPARE THE EFFECT ON SYMPATHETIC ACTIVITY AND HEMODYNAMIC PROFILE OF BARNIDIPINE AND AMLODIPINE IN PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION. | |||||||||||||
Medical condition: Mild to moderate hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000690-34 | Sponsor Protocol Number: 0954A-327 | Start Date*: 2007-05-29 | |||||||||||
Sponsor Name:Merck Sharp & Dohme OÜ | |||||||||||||
Full Title: A Randomized, Double-Blind, Active Comparator Study to Evaluate the Antihypertensive Efficacy and Safety of Losartan/HCTZ Combination as Compared to Losartan Monotherapy in Pediatric Patients With ... | |||||||||||||
Medical condition: Essential Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Prematurely Ended) FI (Prematurely Ended) LT (Prematurely Ended) HU (Completed) DE (Completed) GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016738-28 | Sponsor Protocol Number: ALISEI | Start Date*: 2009-12-11 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA PISANA | |||||||||||||
Full Title: Phase IV prospective, randomized, open with blind endpoints, parallel group study to evaluate the effect of Aliskiren on endothelial dysfunction in patients with essential hypertension | |||||||||||||
Medical condition: essential hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000631-25 | Sponsor Protocol Number: 2007-000631-25 | Start Date*: 2010-06-08 | |||||||||||
Sponsor Name:KAROLINSKA INSTITUTET | |||||||||||||
Full Title: THE ANTITTHROMBOTIC EFFECTS OF DOXAZOSIN AND RAMIPRIL IN ESSENTIAL HYPERTENSION | |||||||||||||
Medical condition: ESSENTIAL HYPERTENSION | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001001-41 | Sponsor Protocol Number: PR002-CLN-pro008 | Start Date*: 2008-06-02 | ||||||||||||||||||||||||||
Sponsor Name:Protherics Medicines Development Ltd, a BTG plc company | ||||||||||||||||||||||||||||
Full Title: A Randomized, Double Blind, Placebo Controlled Study of the Efficacy and Safety of Angiotensin Therapeutic Vaccine (ATV) in Patients With Mild to Moderate Hypertension | ||||||||||||||||||||||||||||
Medical condition: Men and women, 35-70 years old with mild to moderate Hypertension as classified by the British Hypertension Society (BHS) Guidelines - BHS-IV based on the following crietia of sitting blood pressur... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002422-29 | Sponsor Protocol Number: 1235.8 | Start Date*: 2007-10-19 | |||||||||||
Sponsor Name:Boehringer Ingelheim Ltd. | |||||||||||||
Full Title: An open-label follow-up trial of the efficacy and safety of chronic administration of the combination of telmisartan 40mg + amlodipine 10mg or the combination of telmisartan 80mg + amlodipine 10mg ... | |||||||||||||
Medical condition: essential hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) GB (Completed) AT (Completed) CZ (Completed) ES (Completed) IT (Completed) BG (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017155-10 | Sponsor Protocol Number: 10-aifa-2005-01 | Start Date*: 2006-11-07 | |||||||||||
Sponsor Name:CASA DI CURA PRIVATA S.RAFFAELE - PISANA | |||||||||||||
Full Title: Evaluation of tolerability and efficacy of the combination Sildenafil/Bosentan in patients with severe pulmonary hypertension. | |||||||||||||
Medical condition: severe pulmonary hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011156-21 | Sponsor Protocol Number: CCFM 119/209 | Start Date*: 2011-04-28 | |||||||||||
Sponsor Name:FONDAZIONE MONZINO CENTRO CARDIOLOGICO | |||||||||||||
Full Title: Effects of beta-blockers on exercise performance in uncomplicated hypertension | |||||||||||||
Medical condition: Non complicated arterial hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004224-37 | Sponsor Protocol Number: EREMIT | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Universität Leipzig | |||||||||||||
Full Title: Everolimus in der Therapie von Patienten mit pulmonaler Hypertonie | |||||||||||||
Medical condition: - steady or progressive pulmonary hypertension accompanied by at least two of the following parameters associated with a poor prognosis: - Cardiac index ≤ 2,1 l/min/m2 - 6 MWD ≤ 380 m - systolic RR... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.